Customers who purchased CVS Pharmacy-branded maximum-strength lidocaine patches, creams, roll-ons, or spray products in recent years have one more day to file a claim in a $3.8 million settlement with the company.

A group of customers has alleged the packaging of the products was deceptive because it led people to believe they provided a "maximum strength" of lidocaine. CVS Pharmacy has denied any wrongdoing but agreed to the settlement to resolve the matter. The deadline for customers to file a claim is Nov. 20.

BIDEN STOKES NEWSOM PRESIDENTIAL BUZZ AT APEC EVENT ALONGSIDE CALIFORNIA GOVERNOR

There are two ways customers may submit a claim in the settlement. Consumers may submit up to three claims worth $4.50 per unit without proof of purchase, or they may submit a claim with proof of purchase for $4.50 per unit, with no limit on how many claims they make. The claims can be made with proof or without proof of purchase.

People who purchased the products from Dec. 11, 2017, through July 18, 2023, are eligible for a piece of the settlement. To receive a piece of the settlement, eligble customers must submit a claim.

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

The final approval hearing for the settlement has been scheduled by the court for Dec. 19. At the hearing, customers will be able to speak about the proposed settlement with the pharmacy over the lidocaine products. More information on the settlement, including how to file a claim, can be found on the court-authorized website.

A different class-action settlement with an upcoming deadline is for Capital One customers affected by a hack in which millions of customers' personal information was accessed. Affected Capital One customers have until Nov. 27 to claim a piece of that settlement.